insulin
insulin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Shift Work Schedule、Circadian Rhythm、Insulin Resistance、Circadian Misalignment。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
2 项
已进入 III/IV 期
17 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Washington State University
- Valbiotis
- Colorado State University
- KK Women's and Children's Hospital
- DreaMed Diabetes
- Maastricht University Medical Center
- Children's Hospital of Fudan University
- University of Lausanne
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
加拿大、美国、Singapore、荷兰、中国、瑞士、德国、意大利、法国、Slovenia、丹麦、英国
正在招募患者的 insulin 研究
Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD
不适用招募中加拿大NCT06704321Impact of Circulating and Tissue-specific Lipids on Vascular Function and Insulin Sensitivity in Chronic Night Shift Workers
不适用招募中美国NCT06550115Effect of Tele-exercise on Cardiorespiratory Fitness in Paediatrics
不适用招募中SingaporeNCT06770660Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
不适用招募中美国NCT07599982Long-Term Effects of Walnut Consumption on Brain Function
不适用招募中荷兰NCT07422220Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
不适用招募中中国NCT06198725Age and Insulin Resistance
不适用招募中瑞士NCT01224886A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
IV 期招募中加拿大德国意大利NCT07112339Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System
不适用招募中法国NCT07567170Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
不适用招募中法国NCT06618703Vericiguat and Reverse Remodeling Indices in Heart Failure
IV 期招募中SloveniaNCT07405944Comparison Study of Insulin GZR4 With Insulin Degludec
I 期招募中德国NCT07146347Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
I 期 / II 期招募中美国NCT07167693Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance
不适用招募中法国NCT07408479Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
不适用招募中丹麦NCT07240012taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs
不适用招募中英国NCT06844539Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
不适用招募中美国NCT06735651Quinoa Improves Glycolipid Metabolism and Glucose Fluctuation Based on β-Cell Function in Early-stage Type 2 Diabetes
不适用招募中中国NCT07329231Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
不适用招募中比利时丹麦IsraelSloveniaNCT07227805A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases
不适用招募中中国NCT07836088Metabolic Features Effects on FAST Score in MASLD Patients
不适用招募中EgyptNCT06867419Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
不适用招募中CzechiaNCT07611721Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
II 期招募中美国NCT04375657Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
II 期招募中澳大利亚NCT06820281
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。